This is a multifaceted, interdisciplinary program whose objectives are the elucidation of the mechanisms by which three human herpes viruses, i.e., herpes simplex virus 1, herpes simplex virus 2, and Epstein-Barr virus, replicate, maintain themselves in latent infection, and transform cells. The facility also serves as the center for teaching predoctoral and postdoctoral trainees supported by a training grant from the National Cancer Institute and by individual fellowship grants from such sources as National Institutes of Health, the American Cancer Society, Damon Runyon-Walter Winchell Foundation, and the Leukemia Society. The shared facility is the Majorie B. Kovler Viral Oncology Laboratories, which has 35,000 gross sq. ft. and 18,000 net sq. ft. It was designed as a containment facility for use with hazardous virus and was built with the aid of grant from the National Cancer Institute. The facility houses the research programs of Drs. Frenkel, Kieff, Roizman and Spear. These programs currently contain approximately 16 postdoctoral trainees and fellows, 23 predoctoral students, and 20 technical personnel. The facility is fully equipped for research work in molecular virology and oncology. It contains an electron microscope with appropriate accessories, a fully equipped dark room with film developing and printing equipment, high- and low-speed centrifuges, scintillation counters, laminar flow rooms and hood, warm rooms and a cold room, an HP9000 computer with graphics and printing peripherals and terminals throughout the building, glassware washing facilities, a conference room, and miscellaneous other equipment that is shared among the various investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014599-18
Application #
3805527
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
18
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Kathayat, Rahul S; Cao, Yang; Elvira, Pablo D et al. (2018) Active and dynamic mitochondrial S-depalmitoylation revealed by targeted fluorescent probes. Nat Commun 9:334
Liu, Jun; Eckert, Mark A; Harada, Bryan T et al. (2018) m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol 20:1074-1083
Bhanvadia, Raj R; VanOpstall, Calvin; Brechka, Hannah et al. (2018) MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease. Clin Cancer Res 24:3668-3680
Wood, Kevin; Byron, Elizabeth; Janisch, Linda et al. (2018) Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms. Am J Clin Oncol 41:963-966
Sample, Ashley; Zhao, Baozhong; Wu, Chunli et al. (2018) The Autophagy Receptor Adaptor p62 is Up-regulated by UVA Radiation in Melanocytes and in Melanoma Cells. Photochem Photobiol 94:432-437
Hrusch, C L; Manns, S T; Bryazka, D et al. (2018) ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s. Mucosal Immunol 11:61-70
Hope, C Matthew; Webber, Jemma L; Tokamov, Sherzod A et al. (2018) Tuned polymerization of the transcription factor Yan limits off-DNA sequestration to confer context-specific repression. Elife 7:
Wong, Gabrielle S; Zhou, Jin; Liu, Jie Bin et al. (2018) Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition. Nat Med 24:968-977
Wu, Chengyue; Pineda, Federico; Hormuth 2nd, David A et al. (2018) Quantitative analysis of vascular properties derived from ultrafast DCE-MRI to discriminate malignant and benign breast tumors. Magn Reson Med :
Meisel, Marlies; Hinterleitner, Reinhard; Pacis, Alain et al. (2018) Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature 557:580-584

Showing the most recent 10 out of 668 publications